Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» Details

Guru Trades

Q3 2016

IXJ Guru Trades in Q3 2016

Ken Fisher 17,922 sh (+1.69%)
» More
Q4 2016

IXJ Guru Trades in Q4 2016

Ken Fisher 54,887 sh (+206.25%)
» More
Q1 2017

IXJ Guru Trades in Q1 2017

Ken Fisher 12,261 sh (-77.66%)
» More
Q2 2017

IXJ Guru Trades in Q2 2017

Ken Fisher 13,641 sh (+11.26%)
» More

Ratios

vs
industry
vs
history
PE Ratio 24.47
IXJ's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IXJ: 24.47 )
Ranked among companies with meaningful PE Ratio only.
IXJ' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.53
Current: 24.47
0
24.53
PE Ratio without NRI 24.47
IXJ's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IXJ: 24.47 )
Ranked among companies with meaningful PE Ratio without NRI only.
IXJ' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.53
Current: 24.47
0
24.53
PB Ratio 3.79
IXJ's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IXJ: 3.79 )
Ranked among companies with meaningful PB Ratio only.
IXJ' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.8
Current: 3.79
0
3.8

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.56
IXJ's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IXJ: 1.56 )
Ranked among companies with meaningful Dividend Yield % only.
IXJ' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.56
Current: 1.56
0
1.56
5-Year Yield-on-Cost % 1.56
IXJ's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IXJ: 1.56 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IXJ' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.56
Current: 1.56
0
1.56

More Statistics

Short Percentage of Float0.00%
52-Week Range $92.39 - 111.42
Shares Outstanding (Mil)14,650,000.00
» More Articles for IXJ

Headlines

Articles On GuruFocus.com
Cott Announces Agreement to Sell Its Traditional Beverage Manufacturing Business to Refresco in All- Jul 25 2017 
SunPower to Supply 29.9-Megawatts of High Efficiency Solar Panels for Tenergie Solar Projects in Fra Jul 25 2017 
Groupe Eurotunnel SE CEO Interview - H1 2017 Results (video) Jul 25 2017 
UCB and Dermira Announce U.S. and EU Regulatory Submissions for CIMZIA® (certolizumab pegol) for Jul 25 2017 
M.D.C. Holdings Declares Quarterly Cash Dividend Jul 24 2017 
Sarepta Therapeutics Announces Pricing of $325 Million Public Offering of Common Stock Jul 24 2017 
Pacific Biosciences of California, Inc. Second Quarter 2017 Financial Results Call Jul 24 2017 
Farmers Capital Bank Corporation Announces Common Dividend Jul 24 2017 
Cray to Announce Second Quarter 2017 Financial Results on Thursday, July 27 at 4:30 P.M. ET Jul 24 2017 
Webster Financial Corporation Declares Common Dividend Jul 24 2017 

More From Other Websites
Major Developments for Johnson and Johnson Jul 25 2017
Analyst Ratings and Recommendations for Novartis Post 2Q17 Jul 18 2017
Inside Allergan’s International Business Jul 17 2017
How Celgene Stock Performed in 2Q17 Jul 11 2017
Johnson & Johnson’s Medical Devices Business in 1Q17 Jul 05 2017
Performance of Merck’s Diabetes Drugs in 1Q17 Jul 04 2017
Pfizer’s Geographical Performance in 1Q17 Jun 28 2017
Changes in Bristol-Myers Squibb’s Profitability 1Q17 Jun 22 2017
Performance of Elanco in 1Q17 Jun 05 2017
Exploring the Performance of AstraZeneca’s CVMD Segment in 1Q17 May 31 2017
Johnson & Johnson’s Business Segments in 1Q17 May 30 2017
AstraZeneca’s Segment-by-Segment Performance in 1Q17 May 29 2017
Performance of Merck’s Animal Health Segment in 1Q17 May 25 2017
Allergan’s 1Q17 Earnings: Analysts’ Estimates May 08 2017
GlaxoSmithKline’s 1Q17 Estimates: Consumer Healthcare Apr 26 2017
What Analysts Expect of Bristol-Myers Squibb’s 1Q17 Earnings Apr 25 2017
Novartis’s 1Q17 Estimates for Sandoz Apr 24 2017
Johnson & Johnson’s Revenue Estimates: Expect Growth! Apr 13 2017
Examining Gilead Sciences’ 1Q17 Performance Apr 10 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK